Aprea Therapeutics, Inc. ($APRE)
Hamill John P. โ SrVP/CFO/Prin Fin & Acct Ofcr
Shares
5,700
Price
$0.89
Total Value
$5,073.00
P&L
-14.4% ($728.46)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hamill John P. |
|---|---|
| Title | SrVP/CFO/Prin Fin & Acct Ofcr |
| Transaction Date | Jan 30, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 2, 2026 |
| Document Date | Jan 30, 2026 |
| Shares Purchased | 5,700 |
| Price per Share | $0.89 |
| Total Value | $5,073.00 |
| Shares Owned After | 33,433 |
| Derivative | No |
| Accession Number | 0001104659-26-009203 |
| Document | View SEC Filing |